Philipp Gödel

2.2k total citations · 1 hit paper
23 papers, 1.5k citations indexed

About

Philipp Gödel is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Philipp Gödel has authored 23 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 9 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Philipp Gödel's work include CAR-T cell therapy research (16 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Philipp Gödel is often cited by papers focused on CAR-T cell therapy research (16 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Philipp Gödel collaborates with scholars based in Germany and United States. Philipp Gödel's co-authors include Alexander Shimabukuro‐Vornhagen, Matthias Kochanek, Boris Böll, Hans Schlößer, Max Schlaak, Marion Subklewe, Hans‐Joachim Stemmler, Michael S. von Bergwelt‐Baildon, Michael von Bergwelt‐Baildon and Jorge Garcia Borrega and has published in prestigious journals such as Blood, Journal of Virology and Intensive Care Medicine.

In The Last Decade

Philipp Gödel

21 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytokine release syndrome

2018 1.2k citations Alexander Shimabukuro‐Vornhagen, Philipp Gödel et al. Journal for ImmunoTherapy of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philipp Gödel Germany	7	817	422	329	264	254	23	1.5k
Alexandre V. Hirayama United States	14	1.1k 1.3×	277 0.7×	415 1.3×	316 1.2×	267 1.1×	61	1.7k
Bahru Habtemariam United States	12	480 0.6×	202 0.5×	219 0.7×	626 2.4×	167 0.7×	23	1.3k
Michael S. von Bergwelt‐Baildon Germany	23	1.3k 1.5×	1.5k 3.6×	355 1.1×	607 2.3×	256 1.0×	44	2.9k
Yongmin Tang China	16	408 0.5×	323 0.8×	132 0.4×	374 1.4×	62 0.2×	110	1.3k
Usanarat Anurathapan Thailand	17	539 0.7×	226 0.5×	76 0.2×	317 1.2×	100 0.4×	113	1.1k
Xian Zhang China	13	460 0.6×	103 0.2×	356 1.1×	239 0.9×	119 0.5×	54	971
Cristina Gutiérrez United States	11	1.6k 1.9×	449 1.1×	72 0.2×	387 1.5×	108 0.4×	35	1.9k
Yang Cao China	19	638 0.8×	267 0.6×	93 0.3×	277 1.0×	55 0.2×	79	1.1k
George Carrum United States	19	1.9k 2.3×	887 2.1×	240 0.7×	452 1.7×	66 0.3×	50	2.7k
Alison Gulbis United States	15	1.9k 2.3×	826 2.0×	99 0.3×	439 1.7×	120 0.5×	72	2.6k

Countries citing papers authored by Philipp Gödel

Since Specialization

Citations

This map shows the geographic impact of Philipp Gödel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Gödel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Gödel more than expected).

Fields of papers citing papers by Philipp Gödel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp Gödel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Gödel. The network helps show where Philipp Gödel may publish in the future.

Co-authorship network of co-authors of Philipp Gödel

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp Gödel. A scholar is included among the top collaborators of Philipp Gödel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp Gödel. Philipp Gödel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Holtick, Udo, Hyatt Balke‐Want, Sandra Sauer, et al.. (2025). Sequential BCMA CAR T-cell therapy in refractory multiple myeloma. Blood Advances. 9(18). 4624–4630.

Kobbe, Guido, Tobias A.W. Holderried, Martina Crysandt, et al.. (2025). Early Free Light‐Chain Suppression as a Prognostic Marker in Relapsed and Refractory Myeloma Patients Treated With BCMA‐Directed CAR‐T Cells. eJHaem. 6(5). e70139–e70139. 1 indexed citations

Kutsch, Nadine, Philipp Gödel, Conrad‐Amadeus Voltin, et al.. (2024). Long‐term remission in a patient with relapsed Richter's transformation treated with CD19‐directed chimeric antigen‐receptor T‐cells after allogeneic stem cell transplantation. European Journal Of Haematology. 112(6). 984–987. 1 indexed citations

Heger, Jan‐Michel, Jonathan M. Weiss, Christian Becker, et al.. (2024). Noninvasive minimal residual disease assessment in relapsed/refractory large B‐cell lymphoma using digital droplet PCR. European Journal Of Haematology. 112(6). 957–963. 5 indexed citations

Kaddu‐Mulindwa, Dominic, Philipp Gödel, Nadine Kutsch, et al.. (2022). Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 22(7). e498–e506. 1 indexed citations

Kutsch, Nadine, Philipp Gödel, Udo Holtick, et al.. (2022). A Phase I Dose Finding Trial of MB-CART20.1 in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma. Blood. 140(Supplement 1). 12980–12981. 2 indexed citations

Gödel, Philipp, Hyatt Balke‐Want, Francis Ayuk, et al.. (2022). P1184: PHASE I TRIAL OF MB-CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B-CELL NON-HODGKIN LYMPHOMA: 2 YEAR FOLLOW-UP REPORT. HemaSphere. 6. 1070–1071. 2 indexed citations

Heger, Jan‐Michel, Philipp Gödel, Hyatt Balke‐Want, et al.. (2022). Noninvasive, Dynamic Risk Profiling of Primary Central Nervous System Lymphoma By Peripheral Blood Ctdna-Sequencing. Blood. 140(Supplement 1). 3537–3538. 1 indexed citations

Kutsch, Nadine, Philipp Gödel, Conrad‐Amadeus Voltin, et al.. (2022). Sustained Remission of Relapsed Diffuse Large B-cell Lymphoma After Safe Administration of CD19-directed CAR T-cells in a Patient With Chronic Intestinal and Pulmonal GvHD. HemaSphere. 6(7). e735–e735. 1 indexed citations

10.

Naendrup, Jan‐Hendrik, Philipp Gödel, Hyatt Balke‐Want, et al.. (2021). Treatment patterns and disease course of previously untreated Primary Central Nervous System Lymphoma: Feasibility of MTX‐based regimens in clinical routine. European Journal Of Haematology. 107(2). 202–210. 2 indexed citations

11.

Gödel, Philipp, Jan‐Michel Heger, Nadine Kutsch, et al.. (2021). Hematologic Rescue of CAR T-cell–mediated Prolonged Pancytopenia Using Autologous Peripheral Blood Hematopoietic Stem Cells in a Lymphoma Patient. HemaSphere. 5(3). e545–e545. 15 indexed citations

12.

Thelen, Martin, Philipp Gödel, Axel Lechner, et al.. (2020). Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma. Cancer Immunology Immunotherapy. 70(4). 893–907. 105 indexed citations

13.

Borchmann, Peter, Philipp Gödel, Hyatt Balke‐Want, et al.. (2020). Phase I Trial of MB-CART2019.1, a Novel CD20 and CD19 Targeting Tandem Chimeric Antigen Receptor, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma. Blood. 136(Supplement 1). 48–48. 10 indexed citations

14.

Borrega, Jorge Garcia, Philipp Gödel, Oezguer A. Onur, et al.. (2019). In the Eye of the Storm: Immune‐mediated Toxicities Associated With CAR‐T Cell Therapy. HemaSphere. 3(2). e191–e191. 87 indexed citations

15.

Balke‐Want, Hyatt, Philipp Gödel, Nima Abedpour, Martin Peifer, & Peter Borchmann. (2018). Clonal Evolution of a Mutation in PTPRA As a Potential Cause for Resistance Against Anti-CD19 Directed Chimeric Antigen Receptor T-Cell (CAR-T) Therapy with CTL019 in DLBCL Patients. Blood. 132(Supplement 1). 4119–4119. 2 indexed citations

16.

Prinz, Julia, et al.. (2018). CAR, CRS und Neurotoxizität: schwere Komplikationen der Immuntherapie. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 115(3). 198–204. 3 indexed citations

17.

Shimabukuro‐Vornhagen, Alexander, Philipp Gödel, Marion Subklewe, et al.. (2018). Cytokine release syndrome. Journal for ImmunoTherapy of Cancer. 6(1). 56–56. 1161 indexed citations breakdown →

18.

Prinz, Julia, et al.. (2018). Diagnostik und Therapie von immunvermittelten Nebenwirkungen durch Checkpointinhibitoren in der Intensivmedizin. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 115(4). 281–285. 1 indexed citations

19.

Gödel, Philipp, Alexander Shimabukuro‐Vornhagen, & Michael von Bergwelt‐Baildon. (2017). Understanding cytokine release syndrome. Intensive Care Medicine. 44(3). 371–373. 48 indexed citations

20.

Gödel, Philipp, Julia Fischer, Christoph Scheid, et al.. (2016). Familial acquired thrombotic thrombocytopenic purpura in siblings – no immunogenetic link with associated human leucocyte antigens. European Journal Of Haematology. 98(3). 311–313. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact